BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28540772)

  • 1. Management of glaucoma as a neurodegenerative disease.
    Jutley G; Luk SM; Dehabadi MH; Cordeiro MF
    Neurodegener Dis Manag; 2017 Apr; 7(2):157-172. PubMed ID: 28540772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotection in Glaucoma: Animal Models and Clinical Trials.
    Almasieh M; Levin LA
    Annu Rev Vis Sci; 2017 Sep; 3():91-120. PubMed ID: 28731838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disease progression and the need for neuroprotection in glaucoma management.
    Varma R; Peeples P; Walt JG; Bramley TJ
    Am J Manag Care; 2008 Feb; 14(1 Suppl):S15-9. PubMed ID: 18284311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targets of Neuroprotection in Glaucoma.
    He S; Stankowska DL; Ellis DZ; Krishnamoorthy RR; Yorio T
    J Ocul Pharmacol Ther; 2018; 34(1-2):85-106. PubMed ID: 28820649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroprotective therapies in glaucoma: I. Neurotrophic factor delivery.
    Nafissi N; Foldvari M
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016; 8(2):240-54. PubMed ID: 26306832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is neuroprotection a viable therapy for glaucoma?
    Weinreb RN; Levin LA
    Arch Ophthalmol; 1999 Nov; 117(11):1540-4. PubMed ID: 10565524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroprotection in glaucoma: Mechanisms beyond intraocular pressure lowering.
    Tribble JR; Hui F; Quintero H; El Hajji S; Bell K; Di Polo A; Williams PA
    Mol Aspects Med; 2023 Aug; 92():101193. PubMed ID: 37331129
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Translational neuroprotection research in glaucoma: a review of definitions and principles.
    Casson RJ; Chidlow G; Ebneter A; Wood JP; Crowston J; Goldberg I
    Clin Exp Ophthalmol; 2012; 40(4):350-7. PubMed ID: 22697056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin: a candidate neuroprotective agent in the treatment of glaucoma.
    Tsai JC; Song BJ; Wu L; Forbes M
    J Glaucoma; 2007 Sep; 16(6):567-71. PubMed ID: 17873720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leptin as a neuroprotective agent in glaucoma.
    Gupta A
    Med Hypotheses; 2013 Nov; 81(5):797-802. PubMed ID: 24035688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Translational Pharmacology in Glaucoma Neuroprotection.
    Levin LA
    Handb Exp Pharmacol; 2017; 242():209-230. PubMed ID: 27752844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective therapies for glaucoma.
    Song W; Huang P; Zhang C
    Drug Des Devel Ther; 2015; 9():1469-79. PubMed ID: 25792807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective agents in the management of glaucoma.
    Nucci C; Martucci A; Giannini C; Morrone LA; Bagetta G; Mancino R
    Eye (Lond); 2018 May; 32(5):938-945. PubMed ID: 29472700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroprotection in the treatment of glaucoma--A focus on connexin43 gap junction channel blockers.
    Chen YS; Green CR; Danesh-Meyer HV; Rupenthal ID
    Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):182-93. PubMed ID: 25676338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroprotection in glaucoma: drug-based approaches.
    Cheung W; Guo L; Cordeiro MF
    Optom Vis Sci; 2008 Jun; 85(6):406-16. PubMed ID: 18521010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In glaucoma, should enthusiasm about neuroprotection be tempered by the experience obtained in other neurodegenerative disorders?
    Haefliger IO; Fleischhauer JC; Flammer J
    Eye (Lond); 2000 Jun; 14 ( Pt 3B)():464-72. PubMed ID: 11026975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The dawn of neuroprotective therapy for glaucomatous optic neuropathy].
    Yamamoto T
    Nippon Ganka Gakkai Zasshi; 2001 Dec; 105(12):866-83. PubMed ID: 11802458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Status and perspectives of neuroprotective therapies in glaucoma: the European Glaucoma Society White Paper.
    Tamm ER; Schmetterer L; Grehn F
    Cell Tissue Res; 2013 Aug; 353(2):347-54. PubMed ID: 23712457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy.
    Hartwick AT
    Optom Vis Sci; 2001 Feb; 78(2):85-94. PubMed ID: 11265931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should we treat the brain in glaucoma?
    Gupta N; YĆ¼cel YH
    Can J Ophthalmol; 2007 Jun; 42(3):409-13. PubMed ID: 17508036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.